Literature DB >> 12021836

Serotonergic intervention affects both social dominance and affiliative behaviour.

Wai S Tse1, Alyson J Bond.   

Abstract

RATIONALE: Deficiencies in serotonin function have been associated with irritability and aggression but enhancing serotonin has also been shown to promote social status and affiliative behaviour in non-human primates and more recently in humans.
OBJECTIVES: To investigate the effects of citalopram, a selective serotonin reuptake inhibitor (SSRI), on social behaviour with a flatmate and a stranger.
METHODS: Ten pairs of healthy volunteers took part in a randomized double-blind crossover study of 2 weeks treatment with citalopram (20 mg/day) and placebo with a 2-week washout period. In each pair, one person (subject) took the tablets and the other (flatmate) received no treatment. On the last day of each treatment period, the subjects socially interacted with a confederate behaving as a responsive person in a stranger-dyadic social interaction paradigm. After the interaction, subjects played the Mixed-motive game, which measures cooperative behaviour and communication, with the confederate. The flatmates evaluated the social behaviour of the subjects before and at the end of the treatment periods.
RESULTS: On citalopram, the subjects were rated as significantly less submissive by their flatmates and they showed a dominant pattern of eye contact in the stranger-dyadic social interaction paradigm. They also reduced the number of points they awarded themselves and sent more cooperative messages during the game.
CONCLUSIONS: These results indicate that administration of an SSRI can modify social status in different interactions and increase affiliative behaviour. They implicate a role for serotonin in modulating social aspects of behaviour.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021836     DOI: 10.1007/s00213-002-1049-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  47 in total

Review 1.  Evolving the neuroendocrine physiology of human and primate cooperation and collective action.

Authors:  Benjamin C Trumble; Adrian V Jaeggi; Michael Gurven
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-12-05       Impact factor: 6.237

Review 2.  The promise and predicament of cosmetic neurology.

Authors:  A Chatterjee
Journal:  J Med Ethics       Date:  2006-02       Impact factor: 2.903

Review 3.  Possible role of more positive social behaviour in the clinical effect of antidepressant drugs.

Authors:  Simon N Young; Debbie S Moskowitz; Marije aan het Rot
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

4.  The neurobiology of human social behaviour: an important but neglected topic.

Authors:  Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

5.  Peer social interaction is facilitated in juvenile rhesus monkeys treated with fluoxetine.

Authors:  Mari S Golub; Casey E Hogrefe; Alicia M Bulleri
Journal:  Neuropharmacology       Date:  2016-02-22       Impact factor: 5.250

6.  Citalopram intervention for hostility: results of a randomized clinical trial.

Authors:  Thomas W Kamarck; Roger F Haskett; Matthew Muldoon; Janine D Flory; Barbara Anderson; Robert Bies; Bruce Pollock; Stephen B Manuck
Journal:  J Consult Clin Psychol       Date:  2009-02

7.  Changing the Way We Think About (and With) Antidepressants.

Authors:  Andrew M Novick; David A Ross
Journal:  Biol Psychiatry       Date:  2018-08-15       Impact factor: 13.382

Review 8.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

9.  Gender Interacts with Opioid Receptor Polymorphism A118G and Serotonin Receptor Polymorphism -1438 A/G on Speed-Dating Success.

Authors:  Karen Wu; Chuansheng Chen; Robert K Moyzis; Ellen Greenberger; Zhaoxia Yu
Journal:  Hum Nat       Date:  2016-09

10.  Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression.

Authors:  Ulla Knorr; Maj Vinberg; Marianne Klose; Ulla Feldt-Rasmussen; Linda Hilsted; Anders Gade; Eva Haastrup; Olaf Paulson; Jørn Wetterslev; Christian Gluud; Ulrik Gether; Lars Kessing
Journal:  Trials       Date:  2009-08-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.